CJC – 1295

• This product is for pharmaceutical purpose and research.
• This product is to be used for hormonal disorder under the guidance of pediatrition and dermatologist.

Dosage: Adult: SC Growth hormone deficiency Initial: 2 mcg/kg/ thrice a day. May increase dose gradually. Max: 10 mcg/kg/ Thrice a day.

Administration: Intramuscular or Subcutaneous injection.

Warning: Please stirred properly do not shake.Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumour growth. Monitoring in patients with scoliosis is recommended due to risk of progression of scoliosis.

Storage: Store at room temperature away from heat and direct sunlight  pre mixing. Refrigerate between 2-8’C post Mixing.

Contraindications: Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or preproliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment.

About: Growth Releasing Factor aminos 1-29, usually referred to as Modified GRF (1-29) or “ModGRF(1-29),” also known as CJC-1295 without DAC, is a synthetic analog of the endogenous peptide signaling hormone Growth Hormone Releasing Hormone (GHRH). Endogenously produced GHRH has 44 amino acids in its chain structure.The biggest difference between the two is that without DAC the peptide has a much shorter half-life of 30 minutes. This is actually a potentially good thing as it acts more naturally within your body. This means that instead of creating an elongation of growth hormone secretion, your body just gets a quick spurt of growth hormone. In either case, the benefits of CJC 1295 with and without DAC don’t really differ.

What is CJC-1295 ?

A truncated synthetic form of GHRH called Sermorelin or GRF 1-29 has 29 amino acids; Modified GRF (1-29) is further changed in that it has four substituted aminos in its chain that serve the purposes of preventing degradation and oxidation in manufacture and transport as well as in vivo, while also increasing binding affinity to the GHRH receptors.